0000945769-12-000056.txt : 20121212 0000945769-12-000056.hdr.sgml : 20121212 20121212170711 ACCESSION NUMBER: 0000945769-12-000056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121210 FILED AS OF DATE: 20121212 DATE AS OF CHANGE: 20121212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: April Gary M CENTRAL INDEX KEY: 0001463267 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20424 FILM NUMBER: 121259831 MAIL ADDRESS: STREET 1: C/O HI-TECH PHARMACAL CO., INC. STREET 2: 369 BAYVIEW AVENUE CITY: AMITYVILLE STATE: NY ZIP: 11701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC CENTRAL INDEX KEY: 0000887497 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112638720 STATE OF INCORPORATION: NY FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 369 BAYVIEW AVENUE CITY: AMITYVILLE STATE: NY ZIP: 11701 BUSINESS PHONE: 5167898228 MAIL ADDRESS: STREET 1: 369 BAYVIEW AVE. CITY: AMITYVILLE STATE: NY ZIP: 11701 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2012-12-10 0000887497 HI TECH PHARMACAL CO INC HITK 0001463267 April Gary M C/O HI-TECH PHARMACAL CO., INC. 369 BAYVIEW AVENUE AMITYVILLE NY 11701 0 1 0 0 President, HCP Division Common Stock 2012-12-10 4 M 0 1875 5.83 A 1875 D Common Stock 2012-12-10 4 M 0 1875 19.59 A 3750 D Common Stock 2012-12-10 4 M 0 1876 22.25 A 5626 D Common Stock 2012-12-10 4 S 0 5626 35.44 D 0 D Stock Option (Right to Buy) 5.83 2012-12-10 4 M 0 1875 0 D 2009-11-13 2018-11-13 Common Stock 1875 0 D Stock Option (Right to Buy) 19.59 2012-12-10 4 M 0 1875 0 D 2010-11-12 2019-11-12 Common Stock 1875 1875 D Stock Option (Right to Buy) 22.25 2012-12-10 4 M 0 1876 0 D 2011-11-10 2020-11-10 Common Stock 1876 3750 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.21 to $35.71, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote [1] of this Form 4. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a 16b-3 Plan. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2009 Stock Option Plan, which is a 16b-3 Plan. The option became or becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date. Other than the options to acquire 5,625shares reflected on this form as still held by Mr. April following the reported transactions, Mr. April is also the holder of additional options to acquire 25,000 shares of Hi-Tech common stock (for total options to acquire 30,625 shares still held by Mr. April), which options were granted on various dates, with various exercise prices, exercise dates, and expiration dates. Gary M. April 2012-12-12